These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 31398656)

  • 1. Repeated anti-N-methyl-D-aspartate receptor encephalitis coexisting with anti-myelin oligodendrocyte glycoprotein antibody-associated diseases: A case report.
    Aoe S; Kokudo Y; Takata T; Kobara H; Yamamoto M; Touge T; Deguchi K; Masaki T
    Mult Scler Relat Disord; 2019 Oct; 35():182-184. PubMed ID: 31398656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child.
    Sarigecili E; Cobanogullari MD; Komur M; Okuyaz C
    Mult Scler Relat Disord; 2019 Feb; 28():101-103. PubMed ID: 30590238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies.
    Rojc B; Podnar B; Graus F
    J Neuroimmunol; 2019 Mar; 328():86-88. PubMed ID: 30599296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children.
    Hou C; Wu W; Tian Y; Zhang Y; Zhu H; Zeng Y; Peng B; Zheng K; Li X; Chen W
    Mult Scler Relat Disord; 2020 Jul; 42():102018. PubMed ID: 32234601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
    Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual case of anti-MOG CNS demyelination with concomitant mild anti-NMDAR encephalitis.
    Zhou J; Tan W; Tan SE; Hu J; Chen Z; Wang K
    J Neuroimmunol; 2018 Jul; 320():107-110. PubMed ID: 29661538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-NMDAR encephalitis may develop concurrently with anti-MOG antibody-associated bilateral medial frontal cerebral cortical encephalitis and relapse with elevated CSF IL-6 and CXCL13.
    Fujimori J; Takahashi T; Kaneko K; Atobe Y; Nakashima I
    Mult Scler Relat Disord; 2021 Jan; 47():102611. PubMed ID: 33160141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease.
    Pérez CA; Agyei P; Gogia B; Harrison R; Samudralwar R
    J Neuroimmunol; 2020 Feb; 339():577124. PubMed ID: 31837635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observation on the overlapping syndrome of myelin oligodendrocyte glycoprotein antibody and anti-N-methyl-D aspartate receptor in children].
    Gong S; Zhang WH; Ren HT; Li JW; Zhou J; Cheng H; Zhuo XW; Ren CH; Han TL; Lyu JL; Ding CH; Fang F; Guan HZ; Ren XT
    Zhonghua Er Ke Za Zhi; 2020 Jul; 58(7):581-585. PubMed ID: 32605343
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical analysis of a patient simultaneously positive for antibodies of myelin oligodendrocyte glycoprotein and anti-N-methyl-D-aspartate receptor: A case report.
    Cao L; Ren L; Huang X
    Medicine (Baltimore); 2021 Jan; 100(1):e24234. PubMed ID: 33429822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis].
    Nagata S; Nishimura Y; Mitsuo K
    Rinsho Shinkeigaku; 2018 Oct; 58(10):636-641. PubMed ID: 30270341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of adult patients with positive NMDAR-IgG coexisting with MOG-IgG.
    Dai Y; Yuan Y; Bi F; Feng L; Li J; Hu K; Chen S; Huang Q; Li J; Long L; Xiao B; Xie Y; Song Y
    Neurol Sci; 2024 Sep; 45(9):4481-4492. PubMed ID: 38523205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.
    Titulaer MJ; Höftberger R; Iizuka T; Leypoldt F; McCracken L; Cellucci T; Benson LA; Shu H; Irioka T; Hirano M; Singh G; Cobo Calvo A; Kaida K; Morales PS; Wirtz PW; Yamamoto T; Reindl M; Rosenfeld MR; Graus F; Saiz A; Dalmau J
    Ann Neurol; 2014 Mar; 75(3):411-28. PubMed ID: 24700511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature.
    Nan D; Zhang Y; Han J; Jin T
    Neurol Sci; 2021 Mar; 42(3):847-855. PubMed ID: 33409829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China.
    Wang L; ZhangBao J; Zhou L; Zhang Y; Li H; Li Y; Huang Y; Wang M; Lu C; Lu J; Zhao C; Quan C
    Eur J Neurol; 2019 Jan; 26(1):168-174. PubMed ID: 30133068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and radiological features, treatment responses and prognosis in pediatric patients with co-existing anti-N-methyl-D-aspartate receptor and myelin oligodendrocyte glycoprotein antibody-associated encephalitis: A single center study.
    Liao D; Zhong L; Yang L; He F; Deng X; Yin F; Peng J
    Mult Scler Relat Disord; 2024 Jan; 81():105133. PubMed ID: 37984120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies.
    Zhou L; ZhangBao J; Li H; Li X; Huang Y; Wang M; Zhao C; Lu J; Lu C; Li Y; Quan C
    Mult Scler Relat Disord; 2017 Nov; 18():90-92. PubMed ID: 29141829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of steroid therapy in the acute stage of anti-NMDAR and anti-MOG antibody overlapping encephalitis: a case report and literature review.
    Kondo H; Takeuchi Y; Niwa J; Yoshida K; Takemura N; Hosoyama S; Kaga T; Kaneko K; Mabuchi N
    Front Immunol; 2024; 15():1392992. PubMed ID: 38895128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures overlaying anti-N-methyl-D-aspartate receptor encephalitis: A case report.
    Fu Q; Wang G; Che F; Li D; Wang S
    Medicine (Baltimore); 2023 Nov; 102(45):e35948. PubMed ID: 37960781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate.
    Cherian A; Divya KP; Shetty SC; Kannoth S; Thomas B
    Mult Scler Relat Disord; 2020 Nov; 46():102468. PubMed ID: 32906000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.